Flat Footed LLC Grifols Sa Call Options Transaction History

Flat Footed LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$6.27 - $7.7 $221,330 - $271,810	-35,300 Reduced 1.92%	1,803,600 $11.4 Million
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $10.1 Million - $20.9 Million	1,838,900 New	1,838,900 $12.3 Million
Q2 2023 Aug 14, 2023	SELL	$7.14 - $9.29 $214,200 - $278,700	-30,000 Reduced 11.57%	229,300 $2.1 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $1.52 Million - $2.45 Million	229,300 Added 764.33%	259,300 $1.91 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $178,800 - $255,899	30,000 New	30,000 $255,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Flat Footed LLC, based on Form 13F filings with the SEC.

Stay updated on Flat Footed LLC with notifications on news.